Success Story: NAILG Helps Chemical Biology Researcher Secure NIW Approval Following RFE
Client’s Testimonial:
"Thank you for your support throughout the process. It's been a pleasure working with you! NAILG team always provided prompt and constructive responses to my questions, and both the petition letter and response letter were very strong and well-written. Beyond the immigration petition itself, these letters also strengthened my understanding of my career path. Their professionalism and passion are definitely worth the investment!”
On August 20th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Chemical Biology (Approval Notice).
General Field: Chemical Biology
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Taiwan
State at the Time of Case Filing: Texas
Approval Notice Date: August 20th, 2026
Processing Time: 18 months, 30 days (Premium Processing Requested)
Case Summary:
When this NIW petition was filed, the client had already built a research record around chemical biology and the development of biomedical technologies. He held a Ph.D. in chemistry and had authored 9 peer-reviewed journal articles and 2 first-authored conference abstracts. His publications had accumulated 22 citations. His proposed endeavor sought to build upon this background through continued development of nucleic acid therapeutics targeting cancer-related genetic elements, with the aim of advancing cancer treatment and improving patient outcomes.
USCIS did not dispute the importance of that objective when it later issued an RFE. In fact, the officer accepted both the substantial merit and national importance of the proposed endeavor. What remained unresolved was a different question: did the client's past record provide enough evidence that he was well positioned to carry this work forward? USCIS specifically questioned whether his previous research had been sufficiently accepted, implemented, or utilized in the field. This distinction shaped how North America Immigration Law Group (Chen Immigration Law Associates) approached the response.
By then, the record itself had evolved. The client's citations had increased from 22 to 59, and updated comparative evidence provided a clearer picture of where his research stood relative to work by his peers.
Rather than relying on citation rankings alone, the response traced the client’s research into subsequent scientific work to demonstrate its practical impact. Independent researchers actively utilized his findings in investigations involving advanced molecular therapeutics, protein stability, and novel biomaterials. Crucially, experts explicitly noted how his work directly influenced their experimental designs and provided essential empirical support for their methodologies. Furthermore, his research garnered broader industry recognition, including a feature in a scientific media publication that highlighted its significant implications for therapeutic development.
The RFE response further included 4 letters of support, including 2 independent advisory opinions. These letters provided additional context regarding how the client's prior research had contributed to the field and why his experience equipped him to continue advancing clinically relevant nucleic acid technologies.
The case had a lengthy adjudication history. It was initially filed on January 21st, 2025, and premium processing was requested on February 25th, 2026. After USCIS issued the RFE on March 30th, 2026, NAILG focused the response on the one NIW requirement that remained in question and supplemented the record with evidence showing the reach and practical influence of the client's prior work. On August 20th, 2026, USCIS approved the petition after 18 months and 30 days, bringing the case to a successful conclusion and supporting the client's continued work in chemical biology and nucleic acid-based therapeutic research.